Who
David Dieter
EVP & General Counsel
Company insider
Files Form 4 as: EVP & General Counsel, Collegium Pharmaceutical.
In numbers
- Trades disclosed
- 13
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $1.4M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 17 Mar 2025
- Last trade
- 18 Mar 2026
- Last filed
- 3 Apr 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Mar 2026filed 20 Mar 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $488K13,976 at $34.92 | filing |
| 18 Mar 2026filed 20 Mar 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $488K13,976 at $34.92 | filing |
| 17 Mar 2026filed 3 Apr 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $316K8,840 at $35.72 | filing |
| 17 Mar 2026filed 3 Apr 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $316K8,840 at $35.72 | filing |
| 9 Mar 2026filed 11 Mar 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $228K6,224 at $36.65 | filing |
| 9 Mar 2026filed 11 Mar 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $228K6,224 at $36.65 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —22,194 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —9,005 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $130K2,781 at $46.75 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —22,194 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —9,005 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $130K2,781 at $46.75 | filing |
| 17 Mar 2025filed 19 Mar 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —68,449 at $0.00 | filing |
News
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Stock Has Consensus Price Target of $48.71COLL · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name David Dieter; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.